Stamatia Papoutsopoulou

Larisa, ESYE14 41500, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Novel 3-Amino-2-methylquinazolinone NF-κB Inhibitors: Synthesis and Potential Anti-Inflammatory Function.

Novel 3-Amino-2-methylquinazolinone NF-κB Inhibitors: Synthesis and Potential Anti-Inflammatory Function.

Journal: International journal of molecular sciences
Published: June 20, 2026

Association Between Caffeine Levels and Symptom Profile in Schizophrenia: Results from a Cohort Study in Central Greece.

Association Between Caffeine Levels and Symptom Profile in Schizophrenia: Results from a Cohort Study in Central Greece.

Journal: Brain sciences
Published: January 09, 2026

Immunomodulatory Potential of Quinoline Q3, a Selective Inhibitor of the Canonical NF-κB Pathway in Macrophages.

Immunomodulatory Potential of Quinoline Q3, a Selective Inhibitor of the Canonical NF-κB Pathway in Macrophages.

Journal: ChemMedChem
Published: December 16, 2025

"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease".

"Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson's disease".

Journal: NPJ Parkinson's disease
Published: November 18, 2024

A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor Pathway.

A Novel Quinoline Inhibitor of the Canonical NF-κB Transcription Factor Pathway.

Journal: Biology
Published: October 05, 2024

Erythropoietin Reduces Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Bleomycin-Induced Idiopathic Pulmonary Fibrosis.

Erythropoietin Reduces Inflammation, Oxidative Stress, and Apoptosis in a Rat Model of Bleomycin-Induced Idiopathic Pulmonary Fibrosis.

Journal: Journal of personalized medicine
Published: July 26, 2024

Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.

Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.

Journal: International journal of molecular sciences
Published: January 31, 2024

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls.

Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls.

Journal: International journal of molecular sciences
Published: December 09, 2023

Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson's Disease Severity.

Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson's Disease Severity.

Journal: International journal of molecular sciences
Published: November 21, 2022

Parkinson's Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration.

Parkinson's Disease, It Takes Guts: The Correlation between Intestinal Microbiome and Cytokine Network with Neurodegeneration.

Journal: Biology
Published: September 26, 2022

Interleukin-10 Deficiency Impacts on TNF-Induced NFκB Regulated Responses In Vivo.

Interleukin-10 Deficiency Impacts on TNF-Induced NFκB Regulated Responses In Vivo.

Journal: Biology
Published: August 12, 2022

Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.

Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.

Journal: International journal of molecular sciences
Published: August 09, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026